Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis
NCT00116701
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Disease
Interventions
DRUG:
Aranesp®
Sponsor
Amgen